Enveric Biosciences logo
Enveric Biosciences ENVB
$ 5.4 -47.73%

Quarterly report 2025-Q3
added 11-14-2025

report update icon

Enveric Biosciences Market Cap 2011-2025 | ENVB

As of December 12, 2025 Enveric Biosciences has a market cap of $ 2.72 M


Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]

Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.

This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.

Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.

Annual Market Cap Enveric Biosciences

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
739 K 212 K 2.36 M 300 K 1.97 M - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
2.36 M 212 K 1.12 M

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.